Skip to main content
. 2020 Apr 21;38(25):4060–4065. doi: 10.1016/j.vaccine.2020.04.044

Table 1.

Status of US Vaccine Injury Compensation Program (VICP) claims compensated each fiscal year associated with shoulder injury related to vaccine administration (SIRVA) [46] (Division of Injury Compensation Programs, personal communication, March 2020).

Fiscal Year Number of cases compensated for petitioner under age 18 years old Number of cases compensated for petitioner age 18 years or over Total cases compensated SIRVA claims compensated/Total claims compensated (%) Total petitioner compensation paid associated with SIRVA ($) Percent of total VICP petitioner compensation paid associated with SIRVA
2011 1 6 7 7/251 (3%) 1,738,785 0.8%
2012 1 3 4 3/249 (2%) 315,674 0.2%
2013 1 10 11 10/375 (3%) 1,867,457 0.7%
2014 0 39 39 39/365 (11%) 5,325,246 2.6%
2015 3 122 125 122/508 (25%) 17,497,672 8.6%
2016 0 260 260 260/689 (38%) 29,869,178 13.2%
2017 2 286 288 286/706 (41%) 32,231,058 12.8%
2018 0 284 284 284/522 (54%) 26,699,487 13.4%
2019 2 407 409 407/653 (63%) 35,745,300 18.2%
2020* 0 173 173 NA 16,810,818

* Adjudicated claims as to 3/12/2020 for Fiscal Year 2020 (i.e., October 1, 2019 through September 30, 2020). As of 3/12/2020, DICP also reported a backlog of 1,385 pending SIRVA claims (i.e., all accumulated SIRVA claims not yet adjudicated, including some claims for cases that will be dismissed when adjudicated).